Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I love this in regards to dosing:
"They also cite research by Greenwich Biosciences that alleges that CBD is potentially toxic to the liver – a finding that has been disputed by the CED Foundation, who note that the mice in the study were given the human equivalent of 42,050 milligrams of CBD, which they called “an unreasonable amount.”
“In the days where many people are taking 10mg pills of CBD per day, the amounts of CBD that were force-fed to these animals in this study, if translated to humans, would be 4,305mg, 12,915mg, and 43,050mg over 10 days, or 17,220mg, 51,660mg, and 172,200mg in one-shot doses.),” the foundation wrote in a June 20 rebuttal to a Forbes article by Mike Adams. “For reference, these days, most dispensaries sell CBD in doses of 10mg, 20mg, up to 2-300mg.)”
insert-text-here
USDA Sets Target Deadline To Release Hemp Regulations: insert-text-here
FDA extends Public comment period to July 16th: insert-text-here
Terrible law. The point of the law would be that it’s a drug first, which would make sense, but in this case it wasn’t. But there should be some pathways here soon if the fda don’t f it up.
btw I am long. Just explaining the Fed issue. Or trying to. I think it will resolve successfully for us.
Yes - illegally in the eyes of the Feds.
MJNA have been selling it legally since 2012 in certain states.
Yes, but it's been sold illegally - but without enforcement. So now the Feds are trying to create a legal and coherent framework.
I don’t really get the FDA approved drug blocking the ability to put it into the food supply considering CBD has been sold and used as a consumer good prior to that FDA approval.
Progress in Congress:
The FDA amendment, introduced by Rep. Jerry McNerney (D-CA), was approved as part of an en bloc voice vote combining other relatively noncontroversial measures and it did not receive debate on the floor. The measure aims to resolve a problem that the FDA has repeatedly raised since hemp and its derivatives were federally legalized under the 2018 Farm Bill.
Because CBD exists as an FDA-approved drug and has never been allowed in the food supply before, the agency’s former commissioner said Congress may have to pass separate legislation to provide for its lawful marketing.
The amendment’s description directs FDA to “undertake a process to make lawful a safe level for conventional foods and dietary supplements containing cannabidiol (CBD) so long as the products are compliant with all other FDA rules and regulations.”
insert-text-here
Advertising campaign in the UK: insert-text-here
the sell came out from their country and surely went south oon us. $ELLXF
Elixinol Global Ltd. (ELLXF)
2.645 ? -0.065 (-2.40%)
Volume: 161,161 @06/18/19 3:57:29 PM EDT
Bid Ask Day's Range
2.63 2.65 2.64 - 2.74
ELLXF Detailed Quote
Liking how things are shaping up in California in regards to Hemp CBD insert-text-here
I think, ironically, the FDA process will end up putting ELLXF in a good spot. They are almost acting as a moat to keep out some of the big player till there is clarity. During that time ELLXF gets to press it's first mover advantage. ELLXF looks like it should be safe from the FDA in terms of claims & production processes/quality. Plus we have no risk exposure with CBD and food. The pet market - I mean its cats and dogs - let's experiment on Fido! lol. Then it comes down to supplements vs drugs - and I think they will bifurcate the market here with GWPH type drugs on one path and ELLXF supplements on the other.
More change for the better from USPS on CBD: insert-text-here
ELLXF partner Pet Releaf news
https://finance.yahoo.com/news/pet-releaf-grows-england-footprint-120000707.html?soc_src=social-sh&soc_trk=tw
"RFI will also provide all non-CBD ingredients and the manufacturing expertise needed to custom blend formulations for tinctures, CBD-infused powders, capsules and other products."
https://www.fool.com.au/2019/06/11/elixinol-global-share-price-higher-on-strategic-partnership-news/
Elixinol announces strategic partnership with RFI
https://www.elixinolglobal.com/site/PDF/2491_0/StrategicPartnershipwithRFI
Start 19:20 (stop 19:52)
ELLXF: Elixinol raises another $50m, bringing its total fundraising to $120m in 18 months
https://stockhead.com.au/health/elixinol-raises-another-50m-bringing-their-total-fundraising-to-120m-in-18-months/
Elixinol Participates In FDA's First CBD Hearing, Says Guidance, Clarity Will Benefit 'Good Players'
https://www.benzinga.com/markets/cannabis/19/06/13859477/elixinol-participates-in-fdas-first-cbd-hearing-says-guidance-clarity-will-benefit-good-players
Here you go:
Elixinol taps Bell Potter for $50m raising.
Bell Potter was offering clients 12.8 million new Elixinol Global shares at $3.90 each.
The deal was priced at an 8.7% discount to the last close and a 17.6% discount to the five day VWAP.
Funds raised were pegged for US expansion ($32 million); Europe, South America and Asia expansion ($8.2 million); and general working capital ($7.4 million), according to terms sent to potential investors.
Can someone summarize what we're supposed to garner from the ask for a halt and the news? Big drop the past week here but business seems to be growing rapidly.
Thank you.
OTC Markets Group Launches OTCQX Cannabis Index
https://www.otcmarkets.com/stock/ELLXF/news/OTC-Markets-Group-Launches-OTCQX-Cannabis-Index?id=230450
Link and text
https://www.afr.com/business/health/cannabis-stock-taps-bell-potter-for-50m-raising-20190604-p51u8i
ASX-listed Elixinol Global is seeking a $50 million cash injection and has hired Bell Potter Securities to raise the funds from investors.
The company's shares went into a trading halt on Tuesday morning as its broker launched the deal.
Bell Potter was offering clients 12.8 million new Elixinol Global shares at $3.90 each.
The deal was priced at an 8,7 per cent discount to the last close and a 17.6 per cent discount to the five day VWAP.
Funds raised were pegged for US expansion ($32 million); Europe, South America and Asia expansion ($8.2 million); and general working capital ($7.4 million), according to terms sent to potential investors.
Bell Potter was calling for bids by midday Wednesday.
Offered shares priced at an 8.7% discount to EXL's prior close.
ELLXF: Cannabis stock taps Bell Potter for $50m raising
https://www.afr.com/business/health/cannabis-stock-taps-bell-potter-for-50m-raising-20190604-p51u8i
BRIEF-Elixinol Global Seeks Trading Halt
Stock Markets1 hour ago (Jun 04, 2019 10:10)
© Reuters. BRIEF-Elixinol Global Seeks Trading Halt © Reuters. BRIEF-Elixinol Global Seeks Trading Halt
June 4 (Reuters) - Elixinol Global Ltd EXL.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT IN RELATION TO OUTCOME OF A PROPOSED CAPITAL RAISING
Elixinol requested a trading halt on ASX pending an announcement. Keep an eye on this.
Statement from ELLXF on the FDA hearing: insert-text-here
Perfect buying around $2.60 opportunity for 30% profit this week imho
I think the FDA will regulate CBD isolates like Epidiolex differently from full spectrum cbd supplements.
"Lawmakers could also set a threshold concentration for CBD in food and dietary supplements, above which the FDA would regulate the compound as a drug. It is unclear what direction lawmakers will take, but Senate Majority Leader Mitch McConnell (R-KY) suppports boosting the hemp industry in his home state."
'“It could take 2 to 3 years, if we are lucky, for the FDA to put any type of regulations in place,” Beckerman says.
While the industry and consumers wait, “hopefully the reputable companies will be able to preserve the market space,” Wahl says. “A lot of players that are using CBD in their products are trying to do it the right way,” she notes. Under its voluntary program, the US Hemp Authority has certified more than a dozen companies making CBD products. In general, certification aims to ensure that products contain quality CBD, are not contaminated with impurities, and are accurately labeled.'
Followers
|
26
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1174
|
Created
|
09/18/18
|
Type
|
Free
|
Moderators |
50 Pitt Street,
Level 6
Sydney, NSW 2000
Australia
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |